Seattle Genetics Inc /wa Community Page | What other sites are saying about Seattle Genetics Inc /wa

Seattle Genetics Inc /wa

(NQ: SGEN)

35.75 USD -0.95 (-2.59%)

Official Closing Price / Updated: 8:10 PM EDT, May 20, 2013 / Add to My Watchlist

(SGEN) Community Analysis from

Related Wikinvest articles

May 21, 2013

(SGEN) Seattle Genetics Starts SGN-CD19A Phase I Study

(Stock Blog Hub, 2/27/13)

Seattle Genetics Inc. (SGEN) recently commenced two phase I clinical studies with its oncology candidate, SGN-CD19A. The two trials will assess the safety and anti-tumor...(read more)

(SGEN) Seattle Genetics’ Adcetris Earns Approval from Health Canada

(Stock Blog Hub, 2/17/13)

Seattle Genetics Inc. (SGEN) recently received approval from Health Canada for its oncology drug, Adcetris (brentuximab vedotin). Adcetris has been approved...(read more)

How To Profit From An Alternative To Chemotherapy

(Penny Sleuth, 8/20/12)

Over a year ago, I told you about two companies pioneering a new therapeutic platform that provides the benefits of chemotherapy while reducing the side effects. Many of you are familiar with the...(read more)

View all posts about Seattle Genetics (SGEN)

Seattle Genetics (SGEN) Company Overview

There is no analysis for SGEN yet. But you can go to Wikinvest to help create one!

What's in this SGEN analysis on Wikinvest...

Read more analysis on Wikinvest

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates